Last reviewed · How we verify
NCT03720743
Effect of Biodanza on Desire, Excitation and Sexual Inhibition
NA trial testing Biodanza in Sexual Desire Disorder in 73 participants. Completed in 1 June 2018.
1 March 2018
Quick facts
| Lead sponsor | Universidad de Almeria |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 73 |
| Start date | 15 January 2018 |
| Primary completion | 1 March 2018 |
| Estimated completion | 1 June 2018 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Biodanza
Conditions studied
- Sexual Desire Disorder — all drugs for Sexual Desire Disorder →
- Sexual Arousal Disorder — all drugs for Sexual Arousal Disorder →
- Sexual Inhibition — all drugs for Sexual Inhibition →
Sponsor
Universidad de Almeria
Who can join
Adults 18 to 30, any sex, with Sexual Desire Disorder or Sexual Arousal Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
the objective of this study was to examine the effects of a 10 weeks biodanza program on the sexual desire and inhibition/arousal of a sample of healthy young adults. A randomized clinical study was carried out, involving a total of 86 young adults divided into Intervention Group (BG) and Control Group (CG), carrying out biodanza sessions during 10 weeks. The Sexual Desire Inventory (SDI) and the Sexual Inhibition/Sexual Arousal-Short Form Scale (SIS/SES-SF) were completed before and after the intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03720743
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sexual Desire Disorder
Currently open trials in the same condition.
- NCT07023822 — WISH, Feasibility of a Factorial Design · NA · active not recruiting
Other Universidad de Almeria trials
Trials by the same sponsor.
- NCT06797817 — Tributyrin Treatment in Mild Alzheimer Disease: Assessment of Butyrate Effects Via the Gut-Brain · Phase 3 · not yet recruiting
- NCT06522893 — Electrical Dry Needling and Therapeutic Exercise Versus Therapeutic Exercise in Patients With Nonspecific Chronic Neck P · NA · completed
- NCT07093242 — Epigenetic Optimization Through Biofrequency Nutrition · NA · not yet recruiting
- NCT07182747 — Feasibility of a Multidisciplinary Student-Led Program to Improve Frailty in Nursing Home Residents · NA · not yet recruiting
- NCT07015281 — Dry Needling With Percutaneous Electrical Nerve Stimulation and Exercises for Non-specific Chronic Neck Pain · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03720743 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad de Almeria
- Last refreshed: 29 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03720743.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing